1. Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1
- Author
-
Bleyer, A. J., Kmoch, S., Antignac, C., Robins, V., Kidd, K., Kelsoe, J. R., Hladik, G., Klemmer, P., Knohl, S. J., Scheinman, S. J., Vo, N., Santi, A., Harris, A., Canaday, O., Weller, N., Hulick, P. J., Vogel, K., Rahbari-Oskoui, F. F., Tuazon, J., Constantinou-Deltas, Constantinos D., Somers, D., Megarbane, A., Kimmel, P. L., Sperati, C. J., Orr-Urtreger, A., Ben-Shachar, S., Waugh, D. A., Mcginn, S., Bleyer Jr., A. J., Hodaňová, K., Vyletal, P., Živná, M., Hart, T. C., Hart, P. S., and Constantinou-Deltas, Constantinos D. [0000-0001-5549-9169]
- Subjects
Male ,Pathology ,glomerulus filtration rate ,Time Factors ,Epidemiology ,urinalysis ,medicine.medical_treatment ,DNA Mutational Analysis ,variable number of tandem repeat ,genetic analysis ,Critical Care and Intensive Care Medicine ,Medullary cystic kidney disease ,Kidney ,Gastroenterology ,Tamm Horsfall glycoprotein ,Risk Factors ,middle aged ,gene mutation ,Registries ,Aged, 80 and over ,adult ,article ,Age Factors ,Middle Aged ,Polycystic Kidney, Autosomal Dominant ,Pedigree ,female ,medicine.anatomical_structure ,Phenotype ,genotyping technique ,Nephrology ,Mutation (genetic algorithm) ,Disease Progression ,Female ,mutational analysis ,Adult ,medicine.medical_specialty ,Adolescent ,Risk Assessment ,Young Adult ,medullary sponge kidney ,male ,Internal medicine ,medicine ,Humans ,Genetic Predisposition to Disease ,human ,chromosome 1 ,Dialysis ,Aged ,Retrospective Studies ,Transplantation ,business.industry ,Mucin-1 ,Editorials ,Retrospective cohort study ,mucin 1 ,medicine.disease ,major clinical study ,renin ,Mutation ,Kidney Failure, Chronic ,Gene-Environment Interaction ,Age of onset ,business ,Kidney disease - Abstract
Background and objectives The genetic cause of medullary cystic kidney disease type 1 was recently identified as a cytosine insertion in the variable number of tandem repeat region of MUC1 encoding mucoprotein-1 (MUC1), a protein that is present in skin, breast, and lung tissue, the gastrointestinal tract, and the distal tubules of the kidney. The purpose of this investigationwas to analyze the clinical characteristics of families and individuals with this mutation. Design, setting, participants, & measurements Families with autosomal dominant interstitial kidney diseasewere referred for genetic analysis over a 14-year period. Families without UMOD or REN mutations prospectively underwent genotyping for the presence of the MUC1 mutation. Clinical characteristics were retrospectively evaluated in individuals with the MUC1 mutation and historically affected individuals (persons who were both related to genetically affected individuals in such a way that ensured that they could be genetically affected and had a history of CKD stage IV or kidney failure resulting in death, dialysis, or transplantation). Results Twenty-four families were identified with the MUC1 mutation. Of 186 family members undergoing MUC1 mutational analysis, the mutation was identified in 95 individuals, 91 individuals did not have the mutation, and111 individuals were identified as historically affected. Individuals with the MUC1 mutation suffered from chronic kidney failure with a widely variable age of onset of end stage kidney disease ranging from 16 to.80 years. Urinalyses revealed minimal protein and no blood. Ultrasounds of 35 individuals showed no medullary cysts. There were no clinical manifestations of the MUC1 mutation detected in the breasts, skin, respiratory system, or gastrointestinal tract. ConclusionMUC1 mutation results in progressive chronic kidney failurewith a bland urinary sediment. The age of onset of end stage kidney disease is highly variable, suggesting that gene-gene or gene-environment interactions contribute to phenotypic variability. © 2014 by the American Society of Nephrology. 9 527 535 Cited By :15
- Published
- 2014